• Musaffe Tuna and Christopher I Amos.
• Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mtuna9@gmail.com.
• Cancer Lett. 2013 Nov 1;340(2):161-70.

AbstractGenomic sequencing has provided critical insights into the etiology of both simple and complex diseases. The enormous reductions in cost for whole genome sequencing have allowed this technology to gain increasing use. Whole genome analysis has impacted research of complex diseases including cancer by allowing the systematic analysis of entire genomes in a single experiment, thereby facilitating the discovery of somatic and germline mutations, and identification of the insertions, deletions, and structural rearrangements, including translocations and inversions, in novel disease genes. Whole-genome sequencing can be used to provide the most comprehensive characterization of the cancer genome, the complexity of which we are only beginning to understand. Hence in this review, we focus on whole-genome sequencing in cancer.Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

32 keywords...

hide…